Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 40, 2010 - Issue 5
Submit an article Journal homepage
92
Views
4
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

Pharmacokinetics of antofloxacin hydrochloride, a novel fluoroquinolone, after single-dose intravenous administration in healthy Chinese male volunteers

J. WangInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing China
,
Y. XiaoInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing ChinaCorrespondence[email protected]
,
Y. LuInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing China
,
Z. KangInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing China
,
M. ZhangInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing China
,
Y. LiuInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing China
,
J. LiangInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing China
,
M. ZhangInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing China
&
T. LiInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing China
 show all
Pages 344-349 | Received 07 Dec 2009, Accepted 25 Jan 2010, Published online: 15 Mar 2010

References

  • Hu JH, Xie L, Liu XD. (2006). Determination of antofloxacin in rat plasma and bile by HPLC and study of its pharmacokinetics. J Chin Pharmaceut Uni 37(2):153–6.
  • Kaitin KI. (1998). Global drug development and international harmonization: the emergence of China as a world pharmaceutical player. Drug Inform J 32:1187S–91S.
  • Li CJ, Chen DY, Chen KX. (2004). Current status of drug discovery and development in China. Chin Bull Life Sci 16(5):324–9.
  • Liang Y, Liu L, Lu SS, Xie L, Kang A, Xie T, Xie Y, Sheng LS, Liu XD, Wang GJ. (2009). Application of a hybrid ion trap/time-of-flight mass spectrometer in metabolite characterization studies: structural identification of the metabolism profile of antofloxacin in rats rapidly using MSn information and accurate mass measurements. J Pharmaceut Biomed Anal 50:1022–5.
  • Lin HY, Shen HL. (2006). Antibiotics clinical usage in general hospital. Chin J Nosocomiol 16(6):681–3.
  • Lode H, Burner K, Keppel P. (1998). Pharmacodynamics of fluoroquinolones. Clin Infect Dis 27:33–9.
  • Meibohm B, Derendore H. (2002). Pharmacokinetic/pharmacodynamic studies in drug product development. J Pharmaceut Sci 91:18–31.
  • Sun YY, Cai H, Tu CH. (2007). A comparative study on juvenile rat knee joint cartilage toxicity of levofloxacin and antofloxacin after intragastric administration. J Toxicol (Chinese) 21(4):293–4.
  • Xiao XM, Xiao YH. (2008). Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection. Acta Pharmacol Sin 29(10):1253–60.
  • Xiao YH, Lu Y, Kang ZS, Hou F, Wang S, Li TY, Liu Y, Xia YH. (2008a). Tolerability and pharmacokinetics of antofloxacin hydrochloride after multiple oral dose administration in healthy Chinese male volunteers. Int J Clin Pharmacol Ther 46(4):172–9.
  • Xiao YH, Lu Y, Kang ZS, Zhang M, Liu Y, Li TY. (2008b). Pharmacokinetics of antofloxacin hydrochloride, a new fluoroquinolone antibiotic, after single oral dose administration in Chinese healthy male volunteers. Biopharm Drug Disposit 29(3):167–72.
  • Yang C, Yuan Z, Huang WX, Liu CW. (2009). A randomized controlled, double-blind and double-stimulation clinical trial of antofloxacin hydrochloride and verse levofloxacin hydrochloride for the treatment of acute respiratory infections. Chin J Antibiot 34(5):316–19.
  • Yu H, Wu JM, Yang YS, Chen KX, Ji RY. (2002). Antibacterial activities of the derivatives YH54 and YH57 of levofloxacin in vitro. Chin Pharmacol Bull 18(1):112–13.
  • Zhu Q, Liao J, Xie L, Wang GJ, Liu XD. (2009). Mechanism-based inhibition of CYP1A2 by antofloxacin, an 8-NH2 derivative of levofloxacin in rats. Xenobiotica 39(4):293–301.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.